{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:06:51Z","timestamp":1786993611781,"version":"build-2736575974"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jvacx.2024.100464","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T13:14:29Z","timestamp":1708694069000},"page":"100464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-0874","authenticated-orcid":false,"given":"Hannah G","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma V","family":"Thorley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossul","family":"Al-Bahadili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalina","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hookham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Karampatsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100464_b0005","unstructured":"United Nations Inter-agency Group for Child Mortality Estimation (UN, IGME). Levels & Trends in Child Mortality [Internet]. 2021. Available from: file:\/\/\/C:\/Users\/User\/Downloads\/UNICEF-IGME-2021-Child-Mortality-Report.pdf."},{"key":"10.1016\/j.jvacx.2024.100464_b0010","unstructured":"World Health Organization. GROUP B STREPTOCOCCUS VACCINE FULL VALUE OF VACCINE ASSESSMENT. Geneva; 2008."},{"key":"10.1016\/j.jvacx.2024.100464_b0015","unstructured":"World Health Organisation. Tetanus vaccine WHO position paper. WEEKLY EPIDEMIOLOGICAL RECORD [Internet]. 2006 [cited 2023 Sep 25];20. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/233093\/WER8120_198-208.PDF?sequence=1."},{"key":"10.1016\/j.jvacx.2024.100464_b0020","doi-asserted-by":"crossref","unstructured":"Yusuf N, Raza AA, Chang-Blanc D, Ahmed B, Hailegebriel T, Luce RR, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries. 2021 [cited 2023 May 24]; Available from: www.thelancet.com\/lancetghVol.","DOI":"10.1016\/S2214-109X(21)00338-7"},{"key":"10.1016\/j.jvacx.2024.100464_b0025","first-page":"378","article-title":"State of the art review: covid-19 vaccination in pregnancy","author":"Badell","year":"2022","journal-title":"The BMJ [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0030","unstructured":"Immunization [Internet]. [cited 2023 Sep 25]. Available from: https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/immunization."},{"key":"10.1016\/j.jvacx.2024.100464_b0035","unstructured":"Ten threats to global health in 2019 [Internet]. [cited 2023 May 24]. Available from: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"issue":"47","key":"10.1016\/j.jvacx.2024.100464_b0040","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/j.vaccine.2015.08.043","article-title":"A systematic review of adverse events following immunization during pregnancy and the newborn period","volume":"33","author":"Fulton","year":"2015","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0045","doi-asserted-by":"crossref","unstructured":"Davies HG, Bowman | Conor, Watson G, Dodd C, Jones CE, Munoz FM, et al. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date. International Journal of Gynecology & Obstetrics [Internet]. 2023 May 16 [cited 2023 May 23];00:1\u201310. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ijgo.14843.","DOI":"10.1002\/ijgo.14843"},{"issue":"47","key":"10.1016\/j.jvacx.2024.100464_b0050","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1016\/j.vaccine.2015.07.112","article-title":"Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions","volume":"33","author":"Munoz","year":"2015","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0055","unstructured":"Case Definitions Archives - Brighton Collaboration [Internet]. [cited 2021 Sep 19]. Available from: https:\/\/brightoncollaboration.us\/category\/pubs-tools\/case-definitions\/."},{"key":"10.1016\/j.jvacx.2024.100464_b0060","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021 Mar 29 [cited 2021 Oct 5];372. Available from: https:\/\/www.bmj.com\/content\/372\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"10.1016\/j.jvacx.2024.100464_b0065","article-title":"A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection","volume":"13(1)","author":"Calvert","year":"2022","journal-title":"Nat Commun [Internet]"},{"issue":"23","key":"10.1016\/j.jvacx.2024.100464_b0070","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.vaccine.2018.04.050","article-title":"Dengue vaccination during pregnancy - an overview of clinical trials data","volume":"36","author":"Skipetrova","year":"2018","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0075","doi-asserted-by":"crossref","unstructured":"Petousis-Harris H, Howe AS, Jiang Y, Yu L, Watson D, Turner N, et al. A retrospective cohort study of safety outcomes in New Zealand infants exposed to tdap vaccine in utero. Vaccines (Basel) [Internet]. 2019;7(4):147. Available from: https:\/\/www.mdpi.com\/2076-393X\/7\/4\/147\/pdf.","DOI":"10.3390\/vaccines7040147"},{"issue":"34","key":"10.1016\/j.jvacx.2024.100464_b0080","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1016\/j.vaccine.2018.07.011","article-title":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine","volume":"36","author":"Griffin","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100464_b0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Mu\u0148oz","year":"2019","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100464_b0090","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/AOG.0000000000004166","article-title":"Evaluating the association of stillbirths after maternal vaccination in the vaccine safety datalink","volume":"136","author":"Panagiotakopoulos","year":"2020","journal-title":"Obstet Gynecol [Internet]"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100464_b0095","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.vaccine.2020.11.052","article-title":"Safety of maternal pertussis vaccination on pregnancy and birth outcomes: a prospective cohort study","volume":"39","author":"Mohammed","year":"2021","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0100","doi-asserted-by":"crossref","unstructured":"Kharbanda EO, Vazquez-Benitez G, Romitti PA, Naleway AL, Cheetham TC, Lipkind HS, et al. First trimester influenza vaccination and risks for major structural birth defects in offspring HHS public access. J Pediatr [Internet]. 2017 [cited 2023 May 30];187:234\u20139. Available from: www.jpeds.com.","DOI":"10.1016\/j.jpeds.2017.04.039"},{"issue":"33","key":"10.1016\/j.jvacx.2024.100464_b0105","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1016\/j.vaccine.2020.05.059","article-title":"Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants","volume":"38","author":"Munoz","year":"2020","journal-title":"Vaccine [Internet]"},{"issue":"52","key":"10.1016\/j.jvacx.2024.100464_b0110","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1016\/j.vaccine.2018.10.088","article-title":"Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women","volume":"36","author":"Munoz","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100464_b0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N Engl J Med"},{"issue":"44","key":"10.1016\/j.jvacx.2024.100464_b0120","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial","volume":"38","author":"Swamy","year":"2020","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0125","doi-asserted-by":"crossref","unstructured":"Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, et al. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. LANCET HIV [Internet]. 2021 [cited 2023 Jan 30];8:e408-19. Available from: https:\/\/doi.org\/10.1016\/.","DOI":"10.1016\/S2352-3018(20)30339-8"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100464_b0130","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.vaccine.2019.10.105","article-title":"Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial","volume":"38","author":"Perrett","year":"2020","journal-title":"Vaccine [Internet]"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100464_b0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/21645515.2019.1667202","article-title":"Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial","volume":"16","author":"Vesikari","year":"2020","journal-title":"Hum Vaccin Immunother [Internet]"},{"issue":"26","key":"10.1016\/j.jvacx.2024.100464_b0140","first-page":"3605","article-title":"Assessing the feasibility of passive surveillance for maternal immunization safety utilizing archival medical records in Kinshasa","volume":"40","author":"Gadoth","year":"2022","journal-title":"Democratic Repub Congo Vacc"},{"key":"10.1016\/j.jvacx.2024.100464_b0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000035","article-title":"Capability and feasibility of the Global Alignment of Immunisation Safety Assessment in pregnancy criteria for the assessment of pregnancy and birth outcomes in Kinshasa, Democratic Republic of the Congo: a prospective cohort study","author":"Arena","year":"2023","journal-title":"BMJ Public Health [Internet]"},{"issue":"22","key":"10.1016\/j.jvacx.2024.100464_b0150","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/j.vaccine.2012.02.059","article-title":"Safety reporting in developing country vaccine clinical trials\u2014a systematic review","volume":"30","author":"Muehlhans","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100464_b0155","unstructured":"Huang WT, Owen Yang T, Law B, Black S, Sturkenboom M, Chen R. Use and performance of Brighton Collaboration case definitions in low-middle income settings. Abstracts of the 37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, August 23, 2021. . Pharmacoepidemiol Drug Saf. 2021 Aug 1;30:3\u2013439."},{"key":"10.1016\/j.jvacx.2024.100464_b0160","unstructured":"WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization | Elsevier Enhanced Reader. [cited 2021 Nov 22]; Available from: https:\/\/reader.elsevier.com\/reader\/sd\/pii\/S2590136221000401?token=D0122720D96618D08EAE43DAC0FED67FB02DA749B3A96E1417DF5E8A07CCC0B5E3EE7A3BFA187FD219DE20CA631AB4EF&originRegion=eu-west-1&originCreation=20211122100600."},{"key":"10.1016\/j.jvacx.2024.100464_b0165","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med [Internet]. 2010 [cited 2024 Jan 25];8:18. Available from: http:\/\/www.biomedcentral.com\/1741-7015\/8\/18.","DOI":"10.1186\/1741-7015-8-18"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100464_b0170","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/CVI.00375-14","article-title":"Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women","volume":"21","author":"Ma","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100464_b0175","doi-asserted-by":"crossref","first-page":"E157","DOI":"10.1503\/cmaj.130499","article-title":"Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes","volume":"186","author":"Legge","year":"2014","journal-title":"CMAJ [Internet]"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100464_b0180","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ppe.12152","article-title":"Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth","volume":"28","author":"Ahrens","year":"2014","journal-title":"Paediatr Perinat Epidemiol [Internet]"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100464_b0185","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100464_b0190","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/cid\/ciw082","article-title":"Seasonal trivalent influenza vaccination during pregnancy and the incidence of stillbirth: population-based retrospective cohort study","volume":"62","author":"Regan","year":"2016","journal-title":"Clin Infect Dis [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0195","doi-asserted-by":"crossref","unstructured":"Chambers CD, Johnson DL, Xu R, Luo YJ, Louik C, Mitchell AA, et al. Safety of the 2010\u201311, 2011\u201312, 2012\u201313, and 2013\u201314 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine. 2016;34(37):4443\u20139.","DOI":"10.1016\/j.vaccine.2016.06.054"},{"issue":"37","key":"10.1016\/j.jvacx.2024.100464_b0200","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.vaccine.2016.06.078","article-title":"Safety of the 2011\u201312, 2012\u201313, and 2013\u201314 seasonal influenza vaccines in pregnancy: preterm delivery and specific malformations, a study from the case-control arm of VAMPSS","volume":"34","author":"Louik","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100464_b0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciw290","article-title":"The effect of influenza vaccination on birth outcomes in a cohort of pregnant women in lao PDR, 2014\u20132015","volume":"63","author":"Olsen","year":"2016","journal-title":"Clin Infect Dis [Internet]"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100464_b0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial","volume":"17","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100464_b0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijgo.12341","article-title":"Impact of maternal vaccination timing and influenza virus circulation on birth outcomes in rural Nepal","volume":"140","author":"Kozuki","year":"2018","journal-title":"Int J Gynaecol Obstet [Internet]"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100464_b0220","article-title":"Immunogenicity and safety of subunit influenza vaccines in pregnant women","volume":"4","author":"Kostinov","year":"2018","journal-title":"ERJ Open Res [Internet]"},{"issue":"23","key":"10.1016\/j.jvacx.2024.100464_b0225","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1016\/j.vaccine.2017.04.045","article-title":"Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua","volume":"35","author":"Arriola","year":"2017","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12884-018-1712-6","article-title":"Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015","volume":"18(1)","author":"Asavapiriyanont","year":"2018","journal-title":"BMC Pregnancy Childbirth [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0235","article-title":"Influenza vaccination in pregnancy among a group of remote dwelling Aboriginal and Torres Strait Islander mothers in the Northern Territory: The 1+1 Healthy Start to Life study","author":"McHugh","year":"2018","journal-title":"Commun Dis Intell"},{"issue":"13","key":"10.1016\/j.jvacx.2024.100464_b0240","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2019.02.019","article-title":"Association between seasonal influenza vaccination with pre- and postnatal outcomes","volume":"37","author":"Getahun","year":"2019","journal-title":"Vaccine [Internet]"},{"issue":"44","key":"10.1016\/j.jvacx.2024.100464_b0245","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1016\/j.vaccine.2019.09.035","article-title":"Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012\u201313, 2013\u201314, and 2014\u201315","volume":"37","author":"Donahue","year":"2019","journal-title":"Vaccine [Internet]"},{"issue":"36","key":"10.1016\/j.jvacx.2024.100464_b0250","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1016\/j.vaccine.2019.07.024","article-title":"Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes","volume":"37","author":"Sim\u00f5es","year":"2019","journal-title":"Vaccine [Internet]"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100464_b0255","first-page":"e13361","article-title":"Influenza vaccine: A viable option to protect pregnant women and infants from seasonal flu: A retrospective hospital-based study in India","volume":"73","author":"Singh","year":"2019","journal-title":"Int J Clin Pract [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0260","doi-asserted-by":"crossref","unstructured":"Nunes MC, Cutland CL, Moultrie A, Jones S, Ortiz JR, Neuzil KM, et al. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial. Hugo A Stoltenkamp LA, Abdoola Y, van Niekerk N, Treurnicht F SP, editor. Lancet HIV [Internet]. 2020;7(2):e91\u2013103. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med17&NEWS=N&AN=31911146.","DOI":"10.1016\/S2352-3018(19)30322-4"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100464_b0265","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.vaccine.2020.01.059","article-title":"Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development","volume":"38","author":"Avalos","year":"2020","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2020.01.033","article-title":"Safety of influenza vaccination on adverse birth outcomes among pregnant women: A prospective cohort study in Japan","volume":"93","author":"Ohfuji","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100464_b0275","unstructured":"Minassian C, Mangtani P, Peppa M, Thomas SL, McDonald HI, Walker JL, et al. Seasonal influenza vaccination during pregnancy and the risk of major congenital malformations in live-born infants: A 2010-2016 historical cohort study. Clin Infect Dis [Internet]. 2020; Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=emexa&NEWS=N&AN=632168650."},{"key":"10.1016\/j.jvacx.2024.100464_b0280","article-title":"Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study","volume":"26","author":"Mohammed","year":"2020","journal-title":"EClinicalMedicine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0285","doi-asserted-by":"crossref","unstructured":"Speake HA, Pereira G, Regan Gavin; ORCID: http:\/\/orcid.org\/0000-0003-3740-8117 AO - Regan, Annette K.; ORCID: http:\/\/orcid.org\/0000-0002-3879-6193 AKAOP. Risk of adverse maternal and foetal outcomes associated with inactivated influenza vaccination in first trimester of pregnancy. Paediatr Perinat Epidemiol [Internet]. 2021;35(2):196\u2013205. Available from: http:\/\/onlinelibrary.wiley.com\/journal\/10.1111\/(ISSN)1365-3016.","DOI":"10.1111\/ppe.12715"},{"key":"10.1016\/j.jvacx.2024.100464_b0290","unstructured":"McMorrow ML, Rossi L, Meiring S, Bishop K, Itzikowitz R, Isaacs W, et al. A Retrospective observational cohort study of the effect of antenatal influenza vaccination on birth outcomes in Cape Town, South Africa, 2015-2016. Influenza Other Respir Viruses."},{"key":"10.1016\/j.jvacx.2024.100464_b0295","unstructured":"K. P, J. S, K.M. C, E.O. K, T.D. S, E.C. A, et al. Influenza vaccination during pregnancy and risk of selected major structural congenital heart defects, National Birth Defects Prevention Study 2006-2011. Birth Defects Res [Internet]. 2022; Available from: http:\/\/onlinelibrary.wiley.com\/journal\/10.1002\/%28ISSN%292472-1727."},{"key":"10.1016\/j.jvacx.2024.100464_b0300","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ [Internet]"},{"issue":"18","key":"10.1016\/j.jvacx.2024.100464_b0305","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA [Internet]"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100464_b0310","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstetrics Gynecol [Internet]"},{"issue":"15","key":"10.1016\/j.jvacx.2024.100464_b0315","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2015.12790","article-title":"Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations","volume":"314","author":"Sukumaran","year":"2015","journal-title":"JAMA [Internet]"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100464_b0320","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine [Internet]"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100464_b0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100464_b0330","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/21645515.2016.1157241","article-title":"Maternal and infant outcomes among women vaccinated against pertussis during pregnancy","volume":"12","author":"Berenson","year":"2016","journal-title":"Hum Vaccin Immunother [Internet]"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100464_b0335","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007\u20132013","volume":"34","author":"Kharbanda","year":"2016","journal-title":"Vaccine [Internet]"},{"issue":"29","key":"10.1016\/j.jvacx.2024.100464_b0340","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.vaccine.2017.05.041","article-title":"Maternal Tdap vaccination and risk of infant morbidity","volume":"35","author":"Desilva","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100464_b0345","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/21645515.2016.1232786","article-title":"Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women","volume":"13","author":"Villarreal Perez","year":"2017","journal-title":"Hum Vaccin Immunother [Internet]"},{"issue":"33","key":"10.1016\/j.jvacx.2024.100464_b0350","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2017.06.071","article-title":"Prenatal Tdap immunization and risk of maternal and newborn adverse events","volume":"35","author":"Layton","year":"2017","journal-title":"Vaccine [Internet]"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100464_b0355","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2018.01.059","article-title":"Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women","volume":"36","author":"Wanlapakorn","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100464_b0360","article-title":"Prenatal tetanus, diphtheria, acellular pertussis vaccination and autism spectrum disorder","volume":"142","author":"Becerra-Culqui","year":"2018","journal-title":"Pediatrics [Internet]"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100464_b0365","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciy244","article-title":"A Randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response","volume":"67","author":"Halperin","year":"2018","journal-title":"Clin Infect Dis [Internet]"},{"issue":"1 SUPPL. 1","key":"10.1016\/j.jvacx.2024.100464_b0370","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.ajog.2015.10.383","article-title":"Reactogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women","volume":"214","author":"Fortner","year":"2016","journal-title":"Am J Obstet Gynecol [Internet]"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100464_b0375","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1473-3099(18)30717-5","article-title":"Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial","volume":"19","author":"Barug","year":"2019","journal-title":"Lancet Infect Dis [Internet]"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100464_b0380","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/21645515.2019.1627161","article-title":"Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study","volume":"15","author":"Sancovski","year":"2019","journal-title":"Hum Vaccin Immunother [Internet]"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100464_b0385","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/aje\/kwaa074","article-title":"The Association of prenatal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination with attention-deficit\/hyperactivity disorder","volume":"189","author":"Becerra-Culqui","year":"2020","journal-title":"Am J Epidemiol [Internet]"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100464_b0390","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.vaccine.2020.01.009","article-title":"Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women","volume":"38","author":"Hall","year":"2020","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0395","unstructured":"Kerr SM, van Bennekom CM, Mitchell Stephen M.; ORCID: http:\/\/orcid.org\/0000-0001-9442-9737 AO - Van Bennekom, Carla M.; ORCID: http:\/\/orcid.org\/0000-0003-3640-793X AO - Mitchell, Allen A.; ORCID: http:\/\/orcid.org\/0000-0003-0950-6799 AAAOK. Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring. Birth Defects Res [Internet]. 2020;112(5):393\u2013403. Available from: http:\/\/onlinelibrary.wiley.com\/journal\/10.1002\/%28ISSN%292472-1727."},{"key":"10.1016\/j.jvacx.2024.100464_b0400","unstructured":"Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons. NEW ENGLAND JOURNAL OF MEDICINE."},{"key":"10.1016\/j.jvacx.2024.100464_b0405","doi-asserted-by":"crossref","unstructured":"Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol [Internet]. 2021 [cited 2023 Jan 30];225:303.e1-303.e17. Available from: https:\/\/doi.org\/10.1016\/j.ajog.2021.03.023.","DOI":"10.1016\/j.ajog.2021.03.023"},{"issue":"24","key":"10.1016\/j.jvacx.2024.100464_b0410","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100464_b0415","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S1473-3099(22)00426-1","article-title":"Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study","volume":"22","author":"Sadarangani","year":"2022","journal-title":"Lancet Infect Dis [Internet]"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100464_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.04.010","article-title":"Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose","volume":"227","author":"Nevo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100464_b0425","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/uog.26050","article-title":"Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women","volume":"60","author":"Blakeway","year":"2022","journal-title":"Ultrasound Obstet Gynecol [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0430","article-title":"COVID-19 mRNA vaccine in pregnancy: results of the Swiss COVI-PREG registry, an observational prospective cohort study","volume":"18(May)","author":"Favre","year":"2022","journal-title":"Lancet Reg Health - Europe"},{"key":"10.1016\/j.jvacx.2024.100464_b0435","first-page":"1","article-title":"Safety of COVID-19 vaccination in pregnant women: a study of the adverse perinatal outcomes","volume":"November","author":"Kugelman","year":"2022","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jvacx.2024.100464_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.04.022","article-title":"Reductions in stillbirths and preterm birth in COVID-19\u2013vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes","author":"Hui","year":"2022","journal-title":"Am J Obstet Gynecol [Internet]"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100464_b0445","doi-asserted-by":"crossref","first-page":"e2230495","DOI":"10.1001\/jamanetworkopen.2022.30495","article-title":"Analysis of vaccine reactions after COVID-19 vaccine booster doses among pregnant and lactating individuals","volume":"5","author":"Kachikis","year":"2022","journal-title":"JAMA Netw Open [Internet]"},{"issue":"16","key":"10.1016\/j.jvacx.2024.100464_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164720","article-title":"Early adverse events and immune response following second and third COVID-19 vaccination in pregnancy","volume":"11","author":"Toussia-Cohen","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jvacx.2024.100464_b0455","doi-asserted-by":"crossref","unstructured":"Rottenstreich M, Rotem R, Wiener-Well Y, Grisaru-Granovsky S, Sela HY, M. R, et al. Covid-19 third vaccination during pregnancy: maternal and neonatal outcomes-a retrospective study. Arch Gynecol Obstet [Internet]. 2022; Available from: https:\/\/www.springer.com\/medicine\/gynecology\/journal\/404.","DOI":"10.1007\/s00404-022-06786-9"},{"key":"10.1016\/j.jvacx.2024.100464_b0460","doi-asserted-by":"crossref","first-page":"e071416","DOI":"10.1136\/bmj-2022-071416","article-title":"Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study","volume":"378","author":"Fell","year":"2022","journal-title":"BMJ [Internet]"},{"issue":"15","key":"10.1016\/j.jvacx.2024.100464_b0465","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2022.4255","article-title":"Association of COVID-19 Vaccination in Pregnancy with Adverse Peripartum Outcomes","volume":"327","author":"Fell","year":"2022","journal-title":"JAMA"},{"issue":"39","key":"10.1016\/j.jvacx.2024.100464_b0470","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1016\/j.vaccine.2014.07.017","article-title":"Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events","volume":"32","author":"Nordin","year":"2014","journal-title":"Vaccine [Internet]"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100464_b0475","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/1471-0528.13329","article-title":"Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant\u2019s health: cross-sectional linkage study","volume":"123","author":"van der Maas","year":"2016","journal-title":"BJOG [Internet]"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100464_b0480","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.vaccine.2014.01.021","article-title":"Pandemic A\/H1N1 influenza vaccination during pregnancy: a comparative study using the EFEMERIS database","volume":"32","author":"Beau","year":"2014","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0485","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2014.04.015","article-title":"2009 A\/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes - a historical cohort study","volume":"178","author":"Cleary","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0490","article-title":"Evaluation of safety of A\/H1N1 pandemic vaccination during pregnancy: cohort study","volume":"348","author":"Trotta","year":"2014","journal-title":"BMJ [Internet]"},{"issue":"48","key":"10.1016\/j.jvacx.2024.100464_b0495","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2014.09.054","article-title":"Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine [Internet]"},{"issue":"19","key":"10.1016\/j.jvacx.2024.100464_b0500","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.vaccine.2015.03.041","article-title":"A\/H1N1 pandemic influenza vaccination: a retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy","volume":"33","author":"Fabiani","year":"2015","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0505","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejogrb.2015.01.011","article-title":"Adjuvanted vaccines in pregnancy: no evidence for effect of the adjuvanted H1N1\/09 vaccination on occurrence of preeclampsia or intra-uterine growth restriction","volume":"187","author":"Coenders","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol [Internet]"},{"issue":"38","key":"10.1016\/j.jvacx.2024.100464_b0510","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.vaccine.2015.07.061","article-title":"Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: a cohort study of pregnancies stratified by trimester of vaccination","volume":"33","author":"Baum","year":"2015","journal-title":"Vaccine [Internet]"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100464_b0515","doi-asserted-by":"crossref","first-page":"848","DOI":"10.7326\/M16-0139","article-title":"Risk for congenital malformation with H1N1 influenza vaccine: a cohort study with sibling analysis","volume":"165","author":"Ludvigsson","year":"2016","journal-title":"Ann Intern Med [Internet]"},{"issue":"20","key":"10.1016\/j.jvacx.2024.100464_b0520","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.vaccine.2018.03.061","article-title":"A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers","volume":"36","author":"Conlin","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100464_b0525","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/M20-0167","article-title":"Maternal influenza A(H1N1) immunization during pregnancy and risk for autism spectrum disorder in offspring : a cohort study","volume":"173","author":"Ludvigsson","year":"2020","journal-title":"Ann Intern Med [Internet]"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100464_b0530","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/pds.3554","article-title":"Pooled analysis of large and long-term safety data from the human papillomavirus-16\/18-AS04-adjuvanted vaccine clinical trial programme","volume":"23","author":"Angelo","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf [Internet]"},{"issue":"48","key":"10.1016\/j.jvacx.2024.100464_b0535","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1016\/j.vaccine.2015.07.024","article-title":"Risk of spontaneous abortion and other pregnancy outcomes in 15\u201325 year old women exposed to human papillomavirus-16\/18 AS04-adjuvanted vaccine in the United Kingdom","volume":"33","author":"Baril","year":"2015","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0540","doi-asserted-by":"crossref","unstructured":"Panagiotou OA, Befano BL, Gonzalez P, Rodriguez AC, Herrero R, Schiller JT, et al. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. Cortes B Herrero R, Jimenez SE, Porras C, Rodriguez AC, Hildesheim A, Kreimer AR, Lowy DR, Schiffman M, Schiller JT, Sherman M, Wacholder S, Pinto LA, Kemp TJ, Sidawy MK, Quint W, van Doorn LJ, Struijk L, Palefsky JM, Darragh TM, Stoler MH GP, editor. BMJ [Internet]. 2015;351:h4358. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26346155.","DOI":"10.1136\/bmj.h4358"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100464_b0545","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000002191","article-title":"Maternal and infant outcomes after human papillomavirus vaccination in the periconceptional period or during pregnancy","volume":"130","author":"Lipkind","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.jvacx.2024.100464_b0550","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa1612296","article-title":"Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes","volume":"376","author":"Scheller","year":"2017","journal-title":"N Engl J Med [Internet]"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100464_b0555","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/AOG.0000000000002694","article-title":"Risk of spontaneous abortion after inadvertent human papillomavirus vaccination in pregnancy","volume":"132","author":"Kharbanda","year":"2018","journal-title":"Obstetr Gynecol [Internet]"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100464_b0560","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vaccine.2018.11.030","article-title":"Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy","volume":"37","author":"Faber","year":"2019","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0565","doi-asserted-by":"crossref","unstructured":"Bukowinski AT, Hall C, Chang RN, Gumbs GR, Marie S. Conlin A. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy. Vaccine [Internet]. 2020;38(37):5933\u20139. Available from: http:\/\/www.elsevier.com\/locate\/vaccine.","DOI":"10.1016\/j.vaccine.2020.06.073"},{"issue":"4","key":"10.1016\/j.jvacx.2024.100464_b0570","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4340","article-title":"Association of inadvertent 9-valent human papillomavirus vaccine in pregnancy with spontaneous abortion and adverse birth outcomes","volume":"4","author":"Kharbanda","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"20","key":"10.1016\/j.jvacx.2024.100464_b0580","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.vaccine.2016.03.084","article-title":"A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy","volume":"34","author":"Regan","year":"2016","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.jvacx.2024.100464_b0585","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1016\/j.vaccine.2017.04.074","article-title":"No association between influenza vaccination during pregnancy and adverse birth outcomes","volume":"35","author":"Zerbo","year":"2017","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0590","doi-asserted-by":"crossref","unstructured":"Grout L, Martinez-Pino I, Ciglenecki I, Keita S, Diallo AA, Traore B, et al. Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine in guinea: a retrospective cohort study. PLoS Negl Trop Dis [Internet]. 2015;9(12):e0004274. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26713614.","DOI":"10.1371\/journal.pntd.0004274"},{"issue":"11","key":"10.1016\/j.jvacx.2024.100464_b0595","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2017.01.080","article-title":"Safety of the oral cholera vaccine in pregnancy: retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh","volume":"35","author":"Khan","year":"2017","journal-title":"Vaccine [Internet]"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100464_b0600","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(16)30523-0","article-title":"Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study","volume":"17","author":"Ali","year":"2017","journal-title":"Lancet Infect Dis [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0605","doi-asserted-by":"crossref","unstructured":"Khan AI, Ali M, Lynch J, Kabir A, Excler JL, Khan MA, et al. Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial. BMC Infect Dis [Internet]. 2019;19(1):422. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med16&NEWS=N&AN=31092224.","DOI":"10.1186\/s12879-019-4006-3"},{"issue":"3","key":"10.1016\/j.jvacx.2024.100464_b0610","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/kww043","article-title":"Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies","volume":"184","author":"Vazquez-Benitez","year":"2016","journal-title":"Am J Epidemiol [Internet]"},{"issue":"19","key":"10.1016\/j.jvacx.2024.100464_b0615","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1016\/j.vaccine.2017.08.080","article-title":"Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009\u20132010","volume":"36","author":"Eaton","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"2","key":"10.1016\/j.jvacx.2024.100464_b0620","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/AOG.0000000000001190","article-title":"Maternal immunization with an investigational trivalent group B streptococcal vaccine","volume":"127","author":"Donders","year":"2016","journal-title":"Obstetrics and Gynecology [Internet]"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100464_b0625","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis [Internet]"},{"issue":"48","key":"10.1016\/j.jvacx.2024.100464_b0630","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1016\/j.vaccine.2015.10.101","article-title":"PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia","volume":"33","author":"Binks","year":"2015","journal-title":"Vaccine [Internet]"},{"issue":"1","key":"10.1016\/j.jvacx.2024.100464_b0635","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ajo.13002","article-title":"Birth outcomes in Aboriginal mother-infant pairs from the Northern Territory, Australia, who received 23-valent polysaccharide pneumococcal vaccination during pregnancy, 2006\u20132011: the PneuMum randomised controlled trial","volume":"60","author":"McHugh","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol [Internet]"},{"issue":"Suppl 5","key":"10.1016\/j.jvacx.2024.100464_b0640","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1093\/cid\/civ625","article-title":"The safety of PsA-TT in pregnancy: an assessment performed within the navrongo health and demographic surveillance site in ghana","volume":"61","author":"Wak","year":"2015","journal-title":"Clin Infect Dis [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0645","doi-asserted-by":"crossref","unstructured":"Conlin AMS, Sevick CJ, Gumbs GR, Khodr ZG, Bukowinski AT. Safety of inadvertent anthrax vaccination during pregnancy: An analysis of birth defects in the U.S. military population, 2003-2010. Vaccine [Internet]. 2017;35(34):4414\u201320. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgiT=JS&PAGE=reference&D=med14&NEWS=N&AN=28673484.","DOI":"10.1016\/j.vaccine.2017.06.032"},{"issue":"41","key":"10.1016\/j.jvacx.2024.100464_b0650","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1016\/j.vaccine.2018.08.074","article-title":"Uptake and safety of Hepatitis B vaccination during pregnancy: a vaccine safety datalink study","volume":"36","author":"Groom","year":"2018","journal-title":"Vaccine [Internet]"},{"issue":"44","key":"10.1016\/j.jvacx.2024.100464_b0655","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1016\/j.vaccine.2019.09.043","article-title":"Uptake and safety of hepatitis a vaccination during pregnancy: a vaccine safety datalink study","volume":"37","author":"Groom","year":"2019","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0660","doi-asserted-by":"crossref","unstructured":"Khodr ZG, Hall C, Chang RN, Bukowinski AT, Gumbs GR, Conlin Zeina G.; ORCID: http:\/\/orcid.org\/0000-0002-3364-5011 AO - Bukowinski, Anna T.; ORCID: http:\/\/orcid.org\/0000-0002-4621-7227 AMSAOK. Japanese encephalitis vaccination in pregnancy among U.S. active duty military women. Vaccine [Internet]. 2020;38(29):4529\u201335. Available from: http:\/\/www.elsevier.com\/locate\/vaccine.","DOI":"10.1016\/j.vaccine.2020.05.023"},{"issue":"6","key":"10.1016\/j.jvacx.2024.100464_b0665","first-page":"1","article-title":"Safety of yellow fever vaccination in pregnancy: Findings from a cohort of active duty US military women","volume":"27","author":"Hall","year":"2020","journal-title":"J Travel Med [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0670","doi-asserted-by":"crossref","unstructured":"Willis ED, Marko AM, Rasmussen SA, McGee M, Broder KR, Marin M. Merck\/Centers for Disease Control and Prevention Varicella Vaccine Pregnancy Registry: 19-Year Summary of Data From Inception Through Closure, 1995-2013. J Infect Dis [Internet]. 2022;226(Supplement_4):S441\u20139. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med22&NEWS=N&AN=36265854.","DOI":"10.1093\/infdis\/jiac277"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0675","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1016\/j.vaccine.2016.03.038","article-title":"Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Rouse","year":"2016","journal-title":"Vaccine [Internet]"},{"issue":"52","key":"10.1016\/j.jvacx.2024.100464_b0680","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1016\/j.vaccine.2019.05.030","article-title":"Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Kachikis","year":"2019","journal-title":"Vaccine [Internet]"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0685","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1016\/j.vaccine.2016.03.054","article-title":"Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Harrison","year":"2016","journal-title":"Vaccine [Internet]"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0690","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1016\/j.vaccine.2016.03.039","article-title":"Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Kerr","year":"2016","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0695","doi-asserted-by":"crossref","unstructured":"Kachikis A, Eckert LO, Walker C, Oteng-Ntim E, Guggilla R, Gupta M, et al. Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2017;35(48 Pt A):6555\u201362. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150061.","DOI":"10.1016\/j.vaccine.2017.01.043"},{"key":"10.1016\/j.jvacx.2024.100464_b0700","doi-asserted-by":"crossref","unstructured":"Prabhu M, Eckert LO, Belfort M, Babarinsa I, Ananth C V, Silver RM, et al. Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2017;35(48 Pt A):6529\u201337. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150058.","DOI":"10.1016\/j.vaccine.2017.01.081"},{"key":"10.1016\/j.jvacx.2024.100464_b0705","doi-asserted-by":"crossref","unstructured":"Rouse CE, Eckert LO, Babarinsa I, Fay E, Gupta M, Harrison MS, et al. Spontaneous abortion and ectopic pregnancy: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine [Internet]. 2017;35(48 Pt A):6563\u201374. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150062.","DOI":"10.1016\/j.vaccine.2017.01.047"},{"key":"10.1016\/j.jvacx.2024.100464_b0710","doi-asserted-by":"crossref","unstructured":"Boatin AA, Eckert LO, Boulvain M, Grotegut C, Fisher BM, King J, et al. Dysfunctional labor: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2017;35(48 Pt A):6538\u201345. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150059.","DOI":"10.1016\/j.vaccine.2017.01.050"},{"issue":"52","key":"10.1016\/j.jvacx.2024.100464_b0715","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/j.vaccine.2019.09.101","article-title":"Postpartum endometritis and infection following incomplete or complete abortion: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"37","author":"Rouse","year":"2019","journal-title":"Vaccine [Internet]"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0720","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2016.03.042","article-title":"Maternal death: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Patwardhan","year":"2016","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0725","doi-asserted-by":"crossref","unstructured":"Gravett C, Eckert LO, Gravett MG, Dudley DJ, Stringer EM, Mujobu TBM, et al. Non-reassuring fetal status: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2016;34(49):6084\u201392. Available from: http:\/\/dx.doi.org\/10.1016\/j.vaccine.2016.03.043.","DOI":"10.1016\/j.vaccine.2016.03.043"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0730","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.vaccine.2016.03.044","article-title":"Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"34","author":"Tavares Da Silva","year":"2016","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0735","doi-asserted-by":"crossref","unstructured":"Easter SR, Eckert LO, Boghossian N, Spencer R, Oteng-Ntim E, Ioannou C, et al. Fetal growth restriction: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2017;35(48 Pt A):6546\u201354. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150060.","DOI":"10.1016\/j.vaccine.2017.01.042"},{"key":"10.1016\/j.jvacx.2024.100464_b0740","doi-asserted-by":"crossref","unstructured":"Schlaudecker EP, Munoz FM, Bardaji A, Boghossian NS, Khalil A, Mousa H, et al. Small for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine [Internet]. 2017;35(48 Pt A):6518\u201328. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150057.","DOI":"10.1016\/j.vaccine.2017.01.040"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0745","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2016.03.045","article-title":"Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"34","author":"Quinn","year":"2016","journal-title":"Vaccine [Internet]"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0750","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1016\/j.vaccine.2016.03.047","article-title":"Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"DeSilva","year":"2016","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.01.049","article-title":"Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","author":"Cutland","year":"2017","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0760","doi-asserted-by":"crossref","unstructured":"Sweet LR, Keech C, Klein NP, Marshall HS, Tagbo BN, Quine D, et al. Respiratory distress in the neonate: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine [Internet]. 2017;35(48 Pt A):6506\u201317. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150056.","DOI":"10.1016\/j.vaccine.2017.01.046"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0765","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1016\/j.vaccine.2016.03.046","article-title":"Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"34","author":"Vergnano","year":"2016","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0770","doi-asserted-by":"crossref","unstructured":"Ross E, Munoz FM, Edem B, Nan C, Jehan F, Quinn J, et al. Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine [Internet]. 2017;35(48 Pt A):6483\u201391. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150053.","DOI":"10.1016\/j.vaccine.2017.01.051"},{"key":"10.1016\/j.jvacx.2024.100464_b0775","doi-asserted-by":"crossref","unstructured":"Pellegrin S, Munoz FM, Padula M, Heath PT, Meller L, Top K, et al. Neonatal seizures: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2019 Dec 10 [cited 2021 Sep 7];37(52):7596. Available from: \/pmc\/articles\/PMC6899436\/.","DOI":"10.1016\/j.vaccine.2019.05.031"},{"key":"10.1016\/j.jvacx.2024.100464_b0780","doi-asserted-by":"crossref","unstructured":"Sell E, Munoz FM, Soe A, Wiznitzer M, Heath PT, Clarke ED, et al. Neonatal encephalopathy: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine [Internet]. 2017;35(48 Pt A):6501\u20135. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150055.","DOI":"10.1016\/j.vaccine.2017.01.045"},{"issue":"49","key":"10.1016\/j.jvacx.2024.100464_b0785","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.vaccine.2016.03.040","article-title":"Neonatal death: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"34","author":"Pathirana","year":"2016","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.05.027","article-title":"Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data","author":"Villagomez","year":"2019","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.jvacx.2024.100464_b0795","doi-asserted-by":"crossref","unstructured":"DeSilva M, Munoz FM, Sell E, Marshall H, Tse Kawai A, Kachikis A, et al. Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Vaccine [Internet]. 2017;35(48 Pt A):6472\u201382. <http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=med14&NEWS=N&AN=29150052>.","DOI":"10.1016\/j.vaccine.2017.01.044"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100464_bib796","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstet Gynecol."}],"updated-by":[{"DOI":"10.1016\/j.jvacx.2025.100612","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:49:53Z","timestamp":1741999793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":159,"alternative-id":["S2590136224000378"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100464","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100464"}}